Biotech startups backed by corporate venture capitalists are much more likely to be successful at innovating than if they’re funded solely by independent VCs, says Mack senior fellow Gary Dushnitsky.
The Joseph H. Lauder Institute
256 South 37th street
2nd Floor
Philadelphia, PA 19104-6330